Dr. Hening Lin obtained his BS degree in chemistry from Tsinghua University in 1998, and his PhD degree in bio-organic chemistry from Columbia University in New York City in 2003. After his postdoctoral studies at Harvard Medical School, he became a faculty member of Department of Chemistry and Chemical Biology of Cornell University in 2006. His laboratory studies the chemistry, biology, and therapeutic targeting of enzymes, in particular enzymes that control protein post-translational modifications. He was promoted to associate professor in 2012 and full professor in 2013. His awards include Jane Coffin Childs Fellowship, the Camille and Henry Dreyfus New Faculty Award, and ACS Pfizer Award in Enzyme Chemistry. He has been a Howard Hughes Medical Institute Investigator since 2015. He is a review editor for eLIFE and associate editor for ACS Chemical Biology. He is a founder and consultant for Sedec Therapeutics.